| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/02/1997 | WO1997035537A1 Improvements in or relating to encapsulation |
| 10/02/1997 | WO1997030700A3 Composite material for medical, cosmetic and sports purposes and methods for the preparation thereof |
| 10/02/1997 | WO1997019675A3 Complex cationic lipids |
| 10/02/1997 | WO1997013502A3 Prolonged release of gm-csf |
| 10/02/1997 | DE19612084A1 Multiple water-oil-water emulsions preparation |
| 10/02/1997 | DE19608563A1 Preparation for oral delivery of pharmaceutical or nourishing materials |
| 10/02/1997 | CA2250173A1 Cytochrome p450 transducing retroviral vectors |
| 10/02/1997 | CA2250053A1 Polysaccharide microspheres for the pulmonary delivery of drugs |
| 10/02/1997 | CA2250009A1 Diclofenac/gamma-cyclodextrin inclusion compounds |
| 10/02/1997 | CA2249578A1 Polyethylene glycol esters of polyunsaturated fatty acids |
| 10/01/1997 | EP0798001A2 Collagen containing preparations for strengthening bone |
| 10/01/1997 | EP0797996A1 A pharmaceutical or veterinary composition which contains at least one volatile oil, at least one alcohol and at least one fixed oil |
| 10/01/1997 | EP0797992A2 Use of taurine, homotaurine and/or methionine for inducing analgesia or anesthesia and treating or preventing ischaemic injury |
| 10/01/1997 | EP0797991A1 Extended release formulation containing venlafaxine |
| 10/01/1997 | EP0797989A1 Solid pharmaceutical composition comprising leflunomid |
| 10/01/1997 | EP0797988A2 Anti-angiogenic compositions and methods of use |
| 10/01/1997 | EP0797987A1 Sustained-release granular preparation and process for producing the same |
| 10/01/1997 | EP0797986A1 Veterinary compositions containing antibacterials for intramammary use |
| 10/01/1997 | EP0797985A1 Use of an extract of iridaceas in the treatment of skin wrinkles |
| 10/01/1997 | EP0797983A2 Use of methyl ethers in cosmetic and/or pharmaceutical preparations |
| 10/01/1997 | EP0797965A1 Wound dressing and catheter securing using a polyurethane-biopolymer composite |
| 10/01/1997 | EP0797917A1 Iodine/resin disinfectant and a procedure for the preparation thereof |
| 10/01/1997 | EP0797615A2 Polymer microspheres and a method of production thereof |
| 10/01/1997 | EP0797609A1 Polyesters |
| 10/01/1997 | EP0797491A1 Method and apparatus for forming dispenser delivery ports |
| 10/01/1997 | EP0797454A1 Improved adenoviral vectors and producer cells |
| 10/01/1997 | EP0797443A1 A pharmaceutical composition with improved bio-availability of inositol phosphate |
| 10/01/1997 | EP0797441A1 Pharmaceutical composition comprising lamotrigine |
| 10/01/1997 | EP0797435A1 Controlled release matrix for pharmaceuticals |
| 10/01/1997 | EP0797434A1 Reduction of electrostatic forces between magnesium trisilicate adsorbates |
| 10/01/1997 | EP0797433A1 Gas filled microspheres as magnetic resonance imaging contrast agents |
| 10/01/1997 | EP0797432A1 Oil-in-water emulsions |
| 10/01/1997 | EP0797431A1 Aerosol formulations of peptides and proteins |
| 10/01/1997 | EP0797430A1 Foamable formulation and foam |
| 10/01/1997 | EP0797429A1 Osmotic device for the continuous release of active substances into the fluids of the gastro-intestinal tract |
| 10/01/1997 | EP0797428A1 Implantable device |
| 10/01/1997 | EP0797424A1 Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process |
| 10/01/1997 | EP0656021B1 Use of water-soluble or water-dispersible polyurethanes as auxiliary agents in cosmetic and pharmaceutical preparations and polyurethanes containing polylactic acid polyols incorporated by polymerization |
| 10/01/1997 | EP0648272B1 Protein based delivery system |
| 10/01/1997 | EP0627910B1 Methods and apparatus for drug delivery using supercritical solutions |
| 10/01/1997 | EP0538443B1 Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders |
| 10/01/1997 | CN1160999A Non-irritation, non-sensitizing non-ototoxic otic antibacterial compositions |
| 10/01/1997 | CN1160997A Therapeutic vitamin-calcium combination in unitary Galenic tablet form, method for preparing same and use thereof |
| 10/01/1997 | CN1160584A Sustained release formulation of animal growth hormone and process for preparation thereof |
| 10/01/1997 | CN1160574A Kernel-eliminating analgesic ointment |
| 10/01/1997 | CN1160571A Compound Chinese medicine preparation for curing traumatic paraplegia and its preparation technology |
| 10/01/1997 | CN1160570A Burns curing cream and its preparation |
| 10/01/1997 | CN1160563A Chinese patent drug for curing headache |
| 10/01/1997 | CN1160560A Chinese patent drug for curing leukopenia and its preparation process |
| 10/01/1997 | CN1160556A Chinese medicine sedative zhennaowan and its compounding process |
| 10/01/1997 | CN1160553A Marmot oil ointment for burns and scald |
| 10/01/1997 | CN1160548A Process for producing Qingkailing powder injection |
| 10/01/1997 | CN1160547A Rheumatoid disease capsule and its production process |
| 10/01/1997 | CN1160546A Tiepifengdou oral liquid and its compounding process |
| 10/01/1997 | CN1160545A Liver protecting capsule and its production process |
| 10/01/1997 | CN1160543A Marmot oil ointment for tinea pedis, tinea manuum, beriberi and smelly foot |
| 10/01/1997 | CN1160538A Lentinus edodes polysaccharide injecta and its preparation |
| 10/01/1997 | CN1035986C Process for preparing composition of sustained release bolus |
| 10/01/1997 | CA2201413A1 Oral composition of fumagillol derivative |
| 09/30/1997 | US5672687 Medical diagnosis; bone marrow transplants |
| 09/30/1997 | US5672659 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 09/30/1997 | US5672622 Phosphodiesterase inhibitor; rolipram |
| 09/30/1997 | US5672590 Consists of d-ribose, 2-deoxy-d-ribose, alpha-alanine, nicotinic acid and l-ascorbic acid; stimulating the production of cytokines |
| 09/30/1997 | US5672581 Drug delivery; aerosol, programmed, portable, disposable |
| 09/30/1997 | US5672360 24-hour sustained release dosage of morphine or morphine sulfate |
| 09/30/1997 | US5672359 Multicompartment hard capsule with control release properties |
| 09/30/1997 | US5672358 Controlled release aqueous emulsion |
| 09/30/1997 | US5672357 Method and device for implantation of large diameter objects in bovines |
| 09/30/1997 | US5672356 Bioadhesive pharmaceutical composition for the controlled release of active principles |
| 09/30/1997 | US5672336 Process of preparing microparticulate collagen, collagen-based products thereby and method of applying same |
| 09/30/1997 | US5672300 Using multiple spreader boxes |
| 09/30/1997 | US5672167 Controlled release osmotic pump |
| 09/30/1997 | CA2129676C Dextromethorphan antitussive compositions |
| 09/30/1997 | CA2091686C Crystalline modification of 2-dimethylaminoethyl-n-butylaminobenzoate hydrochloride, method for production thereof and pharmaceutical preparation for anesthesia of eyes, based thereon |
| 09/30/1997 | CA2020076C Dental inserts for treatment of periodontal disease |
| 09/27/1997 | CA2201040A1 Solid pharmaceutical preparation, comprising 5-methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide |
| 09/25/1997 | WO1997035200A1 Super-paramagnetic particles with increased r1 relaxivity, processes for producing said particles and use thereof |
| 09/25/1997 | WO1997035012A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
| 09/25/1997 | WO1997034947A1 Conductive adhesives prepared from zwitterionic materials |
| 09/25/1997 | WO1997034932A2 Compositions containing starch excipients |
| 09/25/1997 | WO1997034657A1 Electrode device for iontophoresis |
| 09/25/1997 | WO1997034645A1 Coated bioabsorbable beads for wound treatment |
| 09/25/1997 | WO1997034644A1 Topical formulations for the treatment of nail psoriasis |
| 09/25/1997 | WO1997034622A1 Oral cyclosporin formulations |
| 09/25/1997 | WO1997034610A1 Process for producing efonidipine hydrochloride preparations |
| 09/25/1997 | WO1997034607A1 Topical formulations of aciclovir |
| 09/25/1997 | WO1997034601A1 Drug compositions improved in solubility |
| 09/25/1997 | WO1997034591A1 Alteration of microbial populations in the gastrointestinal tract |
| 09/25/1997 | WO1997034588A1 Propofol microdroplet formulations |
| 09/25/1997 | WO1997034587A2 Transdermal device |
| 09/25/1997 | WO1997034586A2 Device and method for treating ophthalmic diseases |
| 09/25/1997 | WO1997034585A1 Transparent hard capsules |
| 09/25/1997 | WO1997034584A1 Composite gel microparticles as active principle carriers |
| 09/25/1997 | WO1997034583A1 Method for inducing a systemic immune response to an antigen |
| 09/25/1997 | WO1997034582A1 Liposome encapsulated amphiphilic drug compositions |
| 09/25/1997 | WO1997034581A1 Method for solubilising hydrophylic materials (e.g. proteins) in a hydrophobic solvent |
| 09/25/1997 | WO1997034580A1 Suppository composition of the drug which has gastro-intestinal disturbances or undergoes the decomposition by gastric acid |
| 09/25/1997 | WO1997034496A2 Process for addition of sterile gaseous nitrogen and pharmaceutically active substances to solid yoghurt |
| 09/25/1997 | WO1997030024A3 Lipids and their use, for example, in liposomes |
| 09/25/1997 | WO1997029778A3 Bioresponsive pharmacologically-active polymers and articles made therefrom |